Axiom
About Axiom
Axiom is a Wellness startup based in Seoul, South Korea. The company reached Seed stage in August 2026 with a null round led by institutional investors. Axiom's investor base includes 2 institutional funds, with its lead investor leading the most recent equity round.
Axiom is a South Korean longevity startup operating under the mission 'Sustainable Longevity for All', focused on lowering the barriers of price, information, and technology that block healthspan extension for ordinary consumers. The company runs a reinvestment flywheel: generating revenue through affordably priced consumer brands and evidence-based media, then reinvesting a portion of profits into commercialising biotechnology. Its inaugural brand is Roadic (로딕), a skin longevity product line launching in September 2026 that combines a home cold plasma recovery device — the Roadic AirBooster — with three companion cosmetic products formulated to dramatically improve active ingredient absorption through a chemical mechanism involving reactive oxygen species. Axiom uses AI-native operations for rapid marketing experimentation and plans to achieve profitability within one year, with longer-term ambitions to develop personalised longevity solutions informed by consumer data. The company received Seed investment from Kakao Ventures and FuturePlay in August 2026.
Axiom Funding Rounds Timeline
1 rounds
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Seed | August 2026 | Undisclosed | — | — | Kakao Ventures, FuturePlay |
Investors in Axiom
2 institutional investors across 1 rounds
Co-investors
Recent news about Axiom
Questions about Axiom
How much has Axiom raised?
Axiom has raised null across 1 funding round since null.
Who are the investors of Axiom?
Axiom's investors include Kakao Ventures, FuturePlay.
When was Axiom's last funding round?
Axiom's most recent round was a null Seed in August 2026.